NASDAQ · TRUP

Trupanion, Inc.

$23.99 +$0.49 (+2.09%) 1D After hours

Key Metrics

$1.03B
Market cap
P/E · TTM
$1.48B
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow $75.07M
Beta · 1Y 0.24
EBITDA · TTM $45.15M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 3
    From its Feb 5 high, the share price fell 36%.

    Peak close $33.33 on Feb 5; trough close $21.46 on Jun 3. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • Apr 28
    The stock moved -8.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 28
  • Feb 13
    The stock moved -13.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.03B
Enterprise value$749.78M
Shares outstanding43.6M
52-wk range$21.16 – $57.00
Avg volume · 20D575.9K
Net cash $275.30M
Book value / share$9.23
IndustryHospital & Medical Service Plans
ExchangeNASDAQ
About Trupanion, Inc.
IPO dateJul 18, 2014
Employees1121

Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.69
P/FCF13.66
EV/EBITDA16.61
EV/Sales0.51
Graham №

Profitability

Gross
Operating 2.0%
Net
FCF 5.1%
ROE / ROIC — · —

Financial Health

Current ratio1.73
Quick ratio
Debt / equity0.28
Debt / EBITDA 2.42
Net cash $275.30M
Working capital$296.80M

Cash Flow · TTM

Operating CF $88.12M
Capex −$13.05M
Free cash flow $75.07M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

3.0
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings